Literature DB >> 26547864

Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.

Maria Luigia Randi1, Irene Bertozzi2, Elisabetta Cosi2, Claudia Santarossa2, Edoardo Peroni2, Fabrizio Fabris2.   

Abstract

Idiopathic erythrocytosis (IE) is an absolute erythrocytosis with no known cause, diagnosed by exclusion of primary and secondary erythrocytosis. Familial erythrocytosis (FE) is a rare disease and as the rare patients with JAK2-wild-type polycythemia vera (PV) may be misdiagnosed as IE. We compared 78 patients with IE, 21 with FE and 136 with PV in the effort to identify simple features capable of discriminating between them. FE patients were younger at diagnosis either than IE and PV (p < 0.001); IE and FE had lower WBC, platelet counts and higher serum EPO levels, and had splenomegaly and thrombotic events less frequently than PV patients. Phlebotomies to obtain a haematocrit lower than 45 % induce platelet count increase in 70 % of PV but not in IE. Mainly in men, normal spleen, normal platelet counts and no history of thrombosis at diagnosis argue against PV; diagnosis of IE could be supported by means of a cycle of venesection to see how it affects their platelet count. No simple data capable of distinguishing between IE and FE were identified; therefore, a case of sporadic erythrocytosis in a young patient should be investigated as a possible genetic cause.

Entities:  

Keywords:  Familial erythrocytosis; Idiopathic erythrocytosis; Polycythemia vera

Mesh:

Substances:

Year:  2015        PMID: 26547864     DOI: 10.1007/s00277-015-2548-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

Review 1.  Investigation and Management of Erythrocytosis.

Authors:  Mary Frances McMullin
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952

2.  JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.

Authors:  Katarzyna Aleksandra Jalowiec; Kristina Vrotniakaite-Bajerciene; Jakub Jalowiec; Noel Frey; Annina Capraru; Tatiana Wojtovicova; Raphael Joncourt; Anne Angelillo-Scherrer; Andre Tichelli; Naomi Azur Porret; Alicia Rovó
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

3.  Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience.

Authors:  Saša Anžej Doma; Eva Drnovšek; Aleša Kristan; Martina Fink; Matjaž Sever; Helena Podgornik; Tanja Belčič Mikič; Nataša Debeljak; Irena Preložnik Zupan
Journal:  Ann Hematol       Date:  2021-05-19       Impact factor: 3.673

Review 4.  A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.

Authors:  Mary F F McMullin; Adam J Mead; Sahra Ali; Catherine Cargo; Frederick Chen; Joanne Ewing; Mamta Garg; Anna Godfrey; Steven Knapper; Donal P McLornan; Jyoti Nangalia; Mallika Sekhar; Frances Wadelin; Claire N Harrison
Journal:  Br J Haematol       Date:  2018-11-13       Impact factor: 6.998

5.  Retrospective Study of High Hemoglobin Levels in 56 Young Adults.

Authors:  Alexandra Desnoyers; Michel Pavic; Paul-Michel Houle; Jean-Francois Castilloux; Patrice Beauregard; Line Delisle; Richard Le Blanc; Jean Dufresne; Josie-Anne Boisjoly; Vincent Ethier
Journal:  J Hematol       Date:  2018-05-10

6.  Phenotypical differences and thrombosis rates in secondary erythrocytosis versus polycythemia vera.

Authors:  Eliane Nguyen; Michaël Harnois; Lambert Busque; Shireen Sirhan; Sarit Assouline; Ines Chamaki; Harold Olney; Luigina Mollica; Natasha Szuber
Journal:  Blood Cancer J       Date:  2021-04-15       Impact factor: 11.037

Review 7.  JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.

Authors:  Naseema Gangat; Natasha Szuber; Animesh Pardanani; Ayalew Tefferi
Journal:  Leukemia       Date:  2021-05-21       Impact factor: 11.528

8.  Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study.

Authors:  Alpay Yesilaltay; Hasan Degirmenci; Turker Bilgen; Duygu Yasar Sirin; Duygu Bayir; Pelin Degirmenci; Atakan Tekinalp; Seref Alpsoy; Yildiz Okuturlar; Burhan Turgut
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

9.  NGS Evaluation of a Bernese Cohort of Unexplained Erythrocytosis Patients.

Authors:  Katarzyna Aleksandra Jalowiec; Kristina Vrotniakaite-Bajerciene; Annina Capraru; Tatiana Wojtovicova; Raphael Joncourt; Alicia Rovó; Naomi A Porret
Journal:  Genes (Basel)       Date:  2021-12-04       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.